Retraction
Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma
Paper Information
Record ID:
36816
Author(s):
Journal:
Publication Date:
June 18, 2019
Retraction Date:
April 27, 2022
(3.6 years years ago)
Subjects:
Institutions:
- Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, China
- The Sixth Affiliated Hospital, Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Supported by National Key Clinical Discipline, Sun Yat-sen University, Guangzhou, China
- Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations2
Post-Retraction(22.2%)
5
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
642
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Macrophages and angiogenesis in human lymphomas
Doménico Ribatti, Roberto Tamma, Tiziana Annese et al. (5 authors)
Clinical and Experimental Medicine
Open Access
Published: Jan 2024
6 citations
6 citations
642 days after retraction
Paper citing Bevacizumab synergises with the BCL 2 inhibitor ve...
Unknown Authors
Unknown Journal
Published: Jan 2024
614 days after retraction
Retracted: Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B‐cell non‐Hodgkin's lymphoma
Unknown Authors
European Journal Of Haematology
Open Access
Published: Apr 2022
Same day as retraction
The Combination of Jiedu Xiaoluo Decoction with Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Accelerates Disease Remission of Non-Hodgkin Lymphoma
yu zhang, Jingjing Xiang, Ni Zhu et al. (10 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2021
474 days before retraction
Application and research progress of BCL2 inhibitors in elderly patients with hematologic malignancies
Yufan Wang, Liang Wang
Aging Pathobiology and Therapeutics
Open Access
Published: Dec 2020
482 days before retraction
Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth
Lutz Menzel, Uta E. Höpken, Armin Rehm
Frontiers in Immunology
Open Access
Published: Dec 2020
33 citations
33 citations
510 days before retraction
Lymphome du manteau orbitaire traité avec succès par un inhibiteur de Bcl-2 : à propos d’un cas
Elsa Toumi, Fréderic Peyrade, Stéphane Nahon et al. (6 authors)
Journal Français d Ophtalmologie
Open Access
Published: Sep 2020
4 citations
4 citations
580 days before retraction
Bcl-XL: A multifunctional anti-apoptotic protein
Mingxue Li, Dun Wang, Jianhua He et al. (5 authors)
Pharmacological Research
Published: Nov 2019
69 citations
69 citations
895 days before retraction
Quick Stats
Total Citations:
9
Years Since Retraction:
3.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025